Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 6—June 2024
Dispatch

Invasive Pulmonary Aspergillosis in Critically Ill Patients with Hantavirus Infection, Austria

Stefan Hatzl, Laura Scholz, Florian Posch, Philipp Eller, Alexander C. Reisinger, Martin Zacharias, Gregor Gorkiewicz, Martin Hoenigl, Ines Zollner-Schwetz, and Robert KrauseComments to Author 
Author affiliations: Medical University of Graz, Graz, Austria (S. Hatzl,, L. Scholz, F. Posch, P. Eller, A.C. Reisinger, M. Zacharias, G. Gorkiewicz, M. Hoenig, I. Zollner-Schwetz, R. Krause); BioTechMed-Graz, Graz (S. Hatzl, G. Gorkiewicz, M. Hoenigl, R. Krause)

Main Article

Table 2

Characteristics of 2 patients with hantavirus pulmonary aspergillosis and mycological criteria, Graz, Austria*

Characteristic Patient 1, DOBV infection Patient 2, PUUV infection
EORTC risk factors None None
APACHE II score 36 26
Thoracic CT scan/radiograph Bilateral dense infiltrates Bilateral dense infiltrates
Steroids to treat pneumonia Yes Yes
Renal replacement therapy Yes Yes
Vasopressor High-dose nordarenalin and vasopressin High-dose nordarenalin and vasopressin
BAL Aspergillus culture + +
BAL Aspergillus qPCR
BAL galactomannan index 7,11 7,71
Serum Aspergillus qPCR NA NA
β-D-glucan, pg/mL 126 626
Serum galactomannan index 0.79 0.32
Mycologic criteria 4 3
Antifungal therapy Voriconazole Posaconazole
Outcome Dead Alive

*The table summarizes diagnostic and therapeutic characteristics of invasive pulmonary aspergillosis associated with hantavirus-disease. APACHE score, Acute Physiology and Chronic Health Evaluation score; BAL, bronchoalveolar lavage; CT, computed tomography; EORTC, European Organisation for Research and Treatment of Cancer; NA, not available; qPCR, quantitative PCR; +, positive; −, negative.

Main Article

Page created: May 09, 2024
Page updated: May 22, 2024
Page reviewed: May 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external